August 14, 2012

Shipping firms accused of helping Iran

Three U.S. lawmakers urged the Obama administration to take action against two ship registry companies that they claim have violated Iran sanctions.

Algemeiner’s transparent ploy: Naming Romney top non-Jew

I consider Dovid Efune a friend and believe he should be applauded for his work at the Algemeiner Journal. As editor, he has managed to revive and electrify the newspaper. Dubbed in the 70s as the largest Yiddish weekly in the United States, today, in addition to their Yiddish section, the Algemeiner and its website have become well-read sources of news and information on Israel and Jewish happenings for the readers of both English and Yiddish.

Palestian power issues: The night that the lights went out?

The Palestinian Authority (PA) owes more than $170 million to the Israel Electric Company, and Israel is threatening to cut off the flow unless the debt is paid. Palestinian officials say that could cause widespread blackouts throughout the West Bank.

Obituaries: Aug. 17-23, 2012

Leon Aberle died July 3 at 81. Survived by wife Petrina; daughter Carla (Steven) Lenhoff; son Matthew; 3 grandchildren; brother Charles (Saron). Hillside Jeffrey Allyn died July 8 at 75. Survived by wife Harriett; sons Russell (Romel Valerio), Hal (Chantal); 3 grandchildren; sister Flo Barker. Hillside

Calendar Picks and Clicks: Aug. 18-24, 2012

The latest from the Big Jewish Tent cultural series features three simultaneous Shabbat celebrations. Rabbi Ed Feinstein joins Craig Taubman, Shany Zamir, Amir Magal and Josh Nelson, among other artists, performers and presenters at the Ford Amphitheatre (services interpreted in sign language).

Have an invention? Meet an investor in Israel

Israelis love to invent things. Last year, the number of patents granted to Israeli companies in medical instrumentation put it first globally in relation to population size and fourth in terms of number of patents. In relation to its population, Israel consistently ranks tops in the world for bio-pharma and life sciences patents.

More news and opinions than at a
Shabbat dinner, right in your inbox.

More news and opinions than at a Shabbat dinner, right in your inbox.

More news and opinions than at a Shabbat dinner, right in your inbox.